MOR - MorphoSys GAAP EPS of -Euro3.60 revenue of Euro95.8M
- MorphoSys press release ( NASDAQ: MOR ): Q3 GAAP EPS of - €3.60.
- Revenue of €95.8M (+132.5% Y/Y)
- Updated Full Year 2022 Financial Guidance:
- Monjuvi U.S. Net Product Sales - Approx. US$ 90M from prior guidance from US$ 90M to 110M.
For further details see:
MorphoSys GAAP EPS of -€3.60, revenue of €95.8M